 | • レポートコード：MRC2012B0407 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、緑内障治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。緑内障治療の種類別市場規模（プロスタグランジン類似体（PGA）、ベータ遮断薬、アルファアゴニスト）、用途別市場規模（クリニック、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Santen、Akorn、Allergan、Otsuka Pharmaceutical、Pfizer、Zizhu Pharma、Bausch & Lomb、Teva、Lunan Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・緑内障治療の北米市場（アメリカ、カナダ、メキシコ） ・緑内障治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・緑内障治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・緑内障治療の南米市場（ブラジル、アルゼンチン） ・緑内障治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プロスタグランジン類似体（PGA）、ベータ遮断薬、アルファアゴニスト ・用途別分析：クリニック、薬局、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Glaucoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Glaucoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Glaucoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Glaucoma Treatment market has been segmented into:
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
By Application, Glaucoma Treatment has been segmented into:
Clinic
Pharmacy
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glaucoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Glaucoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glaucoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Glaucoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Glaucoma Treatment Market Share Analysis
Glaucoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glaucoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glaucoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Glaucoma Treatment are:
Novartis
Santen
Akorn
Allergan
Otsuka Pharmaceutical
Pfizer
Zizhu Pharma
Bausch & Lomb
Teva
Lunan Pharma
Among other players domestic and global, Glaucoma Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Glaucoma Treatment Market Overview
1.1 Product Overview and Scope of Glaucoma Treatment
1.2 Classification of Glaucoma Treatment by Type
1.2.1 Global Glaucoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Glaucoma Treatment Revenue Market Share by Type in 2019
1.2.3 Prostaglandin Analogs (PGAs)
1.2.4 Beta Blocker
1.2.5 Alpha Agonist
1.3 Global Glaucoma Treatment Market by Application
1.3.1 Overview: Global Glaucoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glaucoma Treatment Market by Regions
1.4.1 Global Glaucoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Glaucoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Glaucoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Glaucoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glaucoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Glaucoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glaucoma Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Santen
2.2.1 Santen Details
2.2.2 Santen Major Business
2.2.3 Santen SWOT Analysis
2.2.4 Santen Product and Services
2.2.5 Santen Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Akorn
2.3.1 Akorn Details
2.3.2 Akorn Major Business
2.3.3 Akorn SWOT Analysis
2.3.4 Akorn Product and Services
2.3.5 Akorn Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Otsuka Pharmaceutical
2.5.1 Otsuka Pharmaceutical Details
2.5.2 Otsuka Pharmaceutical Major Business
2.5.3 Otsuka Pharmaceutical SWOT Analysis
2.5.4 Otsuka Pharmaceutical Product and Services
2.5.5 Otsuka Pharmaceutical Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Product and Services
2.6.4 Pfizer Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zizhu Pharma
2.7.1 Zizhu Pharma Details
2.7.2 Zizhu Pharma Major Business
2.7.3 Zizhu Pharma Product and Services
2.7.4 Zizhu Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bausch & Lomb
2.8.1 Bausch & Lomb Details
2.8.2 Bausch & Lomb Major Business
2.8.3 Bausch & Lomb Product and Services
2.8.4 Bausch & Lomb Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Product and Services
2.9.4 Teva Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Lunan Pharma
2.10.1 Lunan Pharma Details
2.10.2 Lunan Pharma Major Business
2.10.3 Lunan Pharma Product and Services
2.10.4 Lunan Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Glaucoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Glaucoma Treatment Players Market Share
3.2.2 Top 10 Glaucoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Glaucoma Treatment Revenue and Market Share by Regions
4.2 North America Glaucoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Glaucoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Glaucoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Glaucoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Glaucoma Treatment Revenue and Growth Rate (2015-2020)
5 North America Glaucoma Treatment Revenue by Countries
5.1 North America Glaucoma Treatment Revenue by Countries (2015-2020)
5.2 USA Glaucoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Glaucoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Glaucoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe Glaucoma Treatment Revenue by Countries
6.1 Europe Glaucoma Treatment Revenue by Countries (2015-2020)
6.2 Germany Glaucoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Glaucoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France Glaucoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Glaucoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Glaucoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Glaucoma Treatment Revenue by Countries
7.1 Asia-Pacific Glaucoma Treatment Revenue by Countries (2015-2020)
7.2 China Glaucoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Glaucoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Glaucoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India Glaucoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Glaucoma Treatment Revenue and Growth Rate (2015-2020)
8 South America Glaucoma Treatment Revenue by Countries
8.1 South America Glaucoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil Glaucoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Glaucoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Glaucoma Treatment by Countries
9.1 Middle East & Africa Glaucoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Glaucoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Glaucoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Glaucoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Glaucoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Glaucoma Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Glaucoma Treatment Market Forecast by Type (2019-2024)
10.3 Prostaglandin Analogs (PGAs) Revenue Growth Rate (2015-2025)
10.4 Beta Blocker Revenue Growth Rate (2015-2025)
10.5 Alpha Agonist Revenue Growth Rate (2015-2025)
11 Global Glaucoma Treatment Market Segment by Application
11.1 Global Glaucoma Treatment Revenue Market Share by Application (2015-2020)
11.2 Glaucoma Treatment Market Forecast by Application (2019-2024)
11.3 Clinic Revenue Growth (2015-2020)
11.4 Pharmacy Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Glaucoma Treatment Market Size Forecast (2021-2025)
12.1 Global Glaucoma Treatment Market Size Forecast (2021-2025)
12.2 Global Glaucoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America Glaucoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Glaucoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Glaucoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America Glaucoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Glaucoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Glaucoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glaucoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glaucoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Glaucoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Glaucoma Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Novartis Corporate Information, Location and Competitors
Table 7. Novartis Glaucoma Treatment Major Business
Table 8. Novartis Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Novartis SWOT Analysis
Table 10. Novartis Glaucoma Treatment Product and Solutions
Table 11. Novartis Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Santen Corporate Information, Location and Competitors
Table 13. Santen Glaucoma Treatment Major Business
Table 14. Santen Glaucoma Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Santen SWOT Analysis
Table 16. Santen Glaucoma Treatment Product and Solutions
Table 17. Santen Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Akorn Corporate Information, Location and Competitors
Table 19. Akorn Glaucoma Treatment Major Business
Table 20. Akorn Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Akorn SWOT Analysis
Table 22. Akorn Glaucoma Treatment Product and Solutions
Table 23. Akorn Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Allergan Corporate Information, Location and Competitors
Table 25. Allergan Glaucoma Treatment Major Business
Table 26. Allergan Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Allergan SWOT Analysis
Table 28. Allergan Glaucoma Treatment Product and Solutions
Table 29. Allergan Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Otsuka Pharmaceutical Corporate Information, Location and Competitors
Table 31. Otsuka Pharmaceutical Glaucoma Treatment Major Business
Table 32. Otsuka Pharmaceutical Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Otsuka Pharmaceutical SWOT Analysis
Table 34. Otsuka Pharmaceutical Glaucoma Treatment Product and Solutions
Table 35. Otsuka Pharmaceutical Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Pfizer Corporate Information, Location and Competitors
Table 37. Pfizer Glaucoma Treatment Major Business
Table 38. Pfizer Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Pfizer SWOT Analysis
Table 40. Pfizer Glaucoma Treatment Product and Solutions
Table 41. Pfizer Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Zizhu Pharma Corporate Information, Location and Competitors
Table 43. Zizhu Pharma Glaucoma Treatment Major Business
Table 44. Zizhu Pharma Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Zizhu Pharma SWOT Analysis
Table 46. Zizhu Pharma Glaucoma Treatment Product and Solutions
Table 47. Zizhu Pharma Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bausch & Lomb Corporate Information, Location and Competitors
Table 49. Bausch & Lomb Glaucoma Treatment Major Business
Table 50. Bausch & Lomb Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Bausch & Lomb SWOT Analysis
Table 52. Bausch & Lomb Glaucoma Treatment Product and Solutions
Table 53. Bausch & Lomb Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Teva Corporate Information, Location and Competitors
Table 55. Teva Glaucoma Treatment Major Business
Table 56. Teva Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Teva SWOT Analysis
Table 58. Teva Glaucoma Treatment Product and Solutions
Table 59. Teva Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Lunan Pharma Corporate Information, Location and Competitors
Table 61. Lunan Pharma Glaucoma Treatment Major Business
Table 62. Lunan Pharma Glaucoma Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Lunan Pharma SWOT Analysis
Table 64. Lunan Pharma Glaucoma Treatment Product and Solutions
Table 65. Lunan Pharma Glaucoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Glaucoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 67. Global Glaucoma Treatment Revenue Share by Players (2015-2020)
Table 68. Global Glaucoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Glaucoma Treatment Revenue Market Share by Regions (2015-2020)
Table 70. North America Glaucoma Treatment Revenue by Countries (2015-2020)
Table 71. North America Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Table 72. Europe Glaucoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Glaucoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Glaucoma Treatment Revenue by Countries (2015-2020)
Table 75. South America Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Glaucoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Table 78. Global Glaucoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 79. Global Glaucoma Treatment Revenue Share by Type (2015-2020)
Table 80. Global Glaucoma Treatment Revenue Forecast by Type (2021-2025)
Table 81. Global Glaucoma Treatment Revenue by Application (2015-2020)
Table 82. Global Glaucoma Treatment Revenue Share by Application (2015-2020)
Table 83. Global Glaucoma Treatment Revenue Forecast by Application (2021-2025)
Table 84. Global Glaucoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Glaucoma Treatment Picture
Figure 2. Global Glaucoma Treatment Revenue Market Share by Type in 2019
Figure 3. Prostaglandin Analogs (PGAs) Picture
Figure 4. Beta Blocker Picture
Figure 5. Alpha Agonist Picture
Figure 6. Glaucoma Treatment Revenue Market Share by Application in 2019
Figure 7. Clinic Picture
Figure 8. Pharmacy Picture
Figure 9. Other Picture
Figure 10. Global Glaucoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Glaucoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Glaucoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Glaucoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Glaucoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Glaucoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Glaucoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Glaucoma Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Glaucoma Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Glaucoma Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Glaucoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Glaucoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Glaucoma Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Glaucoma Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Glaucoma Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Glaucoma Treatment Revenue Market Share by Countries in 2019
Figure 43. China Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Glaucoma Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Glaucoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Glaucoma Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Glaucoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Glaucoma Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Glaucoma Treatment Revenue Share by Type in 2019
Figure 60. Global Glaucoma Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Prostaglandin Analogs (PGAs) Revenue Growth Rate (2015-2020)
Figure 62. Global Beta Blocker Revenue Growth Rate (2015-2020)
Figure 63. Global Alpha Agonist Revenue Growth Rate (2015-2020)
Figure 64. Global Glaucoma Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Glaucoma Treatment Revenue Share by Application in 2019
Figure 66. Global Glaucoma Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Clinic Revenue Growth Rate (2015-2020)
Figure 68. Global Pharmacy Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Glaucoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Glaucoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Glaucoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Glaucoma Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Glaucoma Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Glaucoma Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Glaucoma Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Glaucoma Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
緑内障治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Treatment D…- 緑内障治療薬の世界市場（～2026年） Market Analysis and Insights: Global Glaucoma Treatment Drugs Market The global Glaucoma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glaucoma Treatment Drugs Scope and Market Size Glaucoma Treatment…
- 緑内障医薬品の世界市場（～2026年） Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqu…
- 緑内障ドレナージ装置の世界市場（～2026年） Market Analysis and Insights: Global Glaucoma Drainage Devices Market The global Glaucoma Drainage Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glaucoma Drainage Devices Scope and Market Size Glaucoma Draina…
- 緑内障の世界市場（～2026年） Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may resul…